The following policies were recently reviewed for annual update. The full texts of these policies are available in the Provider section of bcbsri.com.
- Allergy Testing
- Aqueous Shunts and Stents for Glaucoma
- Comprehensive Genomic Profiling for Selecting Targeted Cancer Therapies (Former Title: Expanded Molecular Panel Testing of Cancers to Identify Targeted Therapies)
- Esophageal pH Monitoring
- Extracorporeal Shock Wave Treatment for Plantar Fasciitis and Other Musculoskeletal Conditions
- Genetic Testing Services
- Lysis of Epidural Adhesions
- Non-Wearable Automatic External Defibrillators (AED)
- Peripheral Artery Disease (PAD) Rehabilitation
- Prior Authorization Via Web-Based Tool for Durable Medical Equipment (DME)
- Prior Authorization Via Web-Based Tool for Procedures
- Semi and Fully Implantable Middle Ear Hearing Aid
- Sphenopalatine Ganglion Block for Headache
- TEMPORARY Cost Share Waiver for Treatment of Confirmed Cases of COVID-19 During the COVID-19 Crisis
- Transesophageal Endoscopic Treatments for Gastroesophageal Reflux Disease
- Vertebral Fracture Assessment
We also post monthly drafts of medical policies being created or reassessed for your review. As a reminder, you can provide comments on draft policies for up to 30 days. Draft policies are located on the Provider homepage, under the Medical Policies section, under the drop-down “Draft Medical Policies.”